Site içinde arama yapın

Anuj Mrfr bir ses eklendi Health
2026-01-23 09:01:22 -

Oncolytic Virotherapy Market: Is 2026 the Year "Living Drugs" Finally Crack the Code of Solid Tumors?
As of January 23, 2026, the oncolytic virotherapy market is identifying as the most high-potential frontier in immuno-oncology, with its 2026 valuation reaching approximately $30 million for specialized platforms, while the broader oncolytic virus therapy sector is projected to hit $1.15 billion by 2030. The 2026 landscape is defined by an explosive CAGR of 23.6% to 26.9%, fueled by the success...

0 Yorumlar 0 hisse senetleri 268 Views 0 önizleme

Please log in to like, share and comment!
Anuj Mrfr bir ses eklendi Health
2026-02-12 06:07:28 -

The "Armed Virus" Revolution: Is 2026 the Year We Start Shipping "Pharmacy-in-a-Virus"?
A major shift in the 2026 global industry is the record-breaking adoption of "Armed Oncolytic Viruses." This year, to cater to the need for multi-layered attacks, the Oncolytic Virotherapy Market has transitioned to viruses that are genetically engineered to carry "payloads" like cytokines (GM-CSF) or bispecific antibodies. This level of "Self-Manufacturing Therapy" is the new gold standard,...

0 Yorumlar 0 hisse senetleri 25 Views 0 önizleme

Please log in to like, share and comment!